| 1 |
2024 |
Kazi N Islam, Rahib K Islam, Victoria T Tong, M Zaid Shami, Kaitlyn E Allen, Jared R Brodtmann, Jordan A Book. Obesity Medications and Their Impact on Cardiovascular Health: A Narrative Review, Cureus. 2024;
https://doi.org/10.7759/cureus.71875 |
| 2 |
2025 |
Ahmed Y. Azzam, Muhammed Amir Essibayi, Dhrumil Vaishnav, Mohammed A. Azab, Mahmoud M. Morsy, Osman Elamin, Adam Elswedy, Oday Atallah, Hana J. Abukhadijah, Adam A. Dmytriw, Amanda Baker, Deepak Khatri, Neil Haranhalli, David J. Altschul. Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study, Annals of Clinical and Translational Neurology. 2025; acn3.52300.
https://doi.org/10.1002/acn3.52300 |
| 3 |
2025 |
Pranav Vasu, Emily A. Dorairaj, Robert N. Weinreb, Alex S. Huang, Syril K. Dorairaj. Risk of Glaucoma in Non-Diabetic Patients using a Glucagon Like Peptide-1 Receptor Agonist, Ophthalmology. 2025;
https://doi.org/10.1016/j.ophtha.2025.02.011 |
| 4 |
2025 |
Ahmed Y. Azzam, Muhammed Amir Essibayi, Nathan Farkas, Mohammed A. Azab, Mahmoud M. Morsy, Osman Elamin, Adam Elswedy, Ahmed Saad Al Zomia, Hammam A. Alotaibi, Ahmed Alamoud, Oday Atallah, Hana J. Abukhadijah, Adam A. Dmytriw, Amanda Baker, Deepak Khatri, Neil Haranhalli, David J. Altschul. Efficacy of Tirzepatide Dual GIP/GLP‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study, Endocrinology, Diabetes & Metabolism. 2025; 8: e70019.
https://doi.org/10.1002/edm2.70019 |
